Sci Transl Med:患莱伦氏综合症为何不会患癌症和糖尿病

2012-02-15 MedSci MedSci原创

近日,国际著名杂志《科学—转化医学》(Science Translational Medicine)在线刊登了美国南加州大学、以及意大利和德国等处的研究人员的最新研究成果“Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy”,在之前研究的基础上,进一步解析

近日,国际著名杂志《科学—转化医学》(Science Translational Medicine)在线刊登了美国南加州大学、以及意大利和德国等处的研究人员的最新研究成果“Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy”,在之前研究的基础上,进一步解析了为什么来自厄瓜多尔的一群患有莱伦氏综合症(Laron Syndrome)的人群不会患上癌症和糖尿病

领导这一研究的是南加州大学Valter Long教授,他的研究组在去年发表文章,报道了对99名生活在偏远村庄的患有莱伦氏综合症(也称为侏儒综合征)的厄瓜多尔人进行了长达22年研究的新成果。

这些有血缘关系的人是西班牙改宗者的后裔,研究人员通过对来自该家族成员血样本中的数千个基因进行了基因表达分析,希望能了解这些人为什么不会患上癌症和糖尿病。结果他们发现这群厄瓜多尔人中的GHR突变,与一种像面包酵母菌这样简单的生物中的基因变化十分相似,这种变化使得该酵母菌可以长寿而且对毒素具有抵抗力。但是这些研究还并没有解析清楚GHR突变激发的具体分子机制是什么、

在最新这项研究中,研究人员通过细胞实验发现,这些厄瓜多尔人的血液中带有一些特殊的成分,能帮助他们应对DNA损伤等,清楚可能发展成癌细胞的细胞。

这种成分就是IGF-1,这是一种在分子结构上与胰岛素类似的多肽蛋白物质,全称为胰岛素样生长因子,也称为生长激素介质,IGF-1在人体内肝细胞、肾细胞、脾细胞等十几种细胞自分泌和旁分泌,对于婴儿的生长和在成人体内持续进行合成代谢作用上具有重要意义。

研究人员发现低浓度IGF-1能帮助应对DNA损伤,并由此激发DNA损伤应答的细胞死亡,而且这种蛋白还与血胰岛素浓度,以及胰岛素敏感性有关,当IGF-1浓度低时,血胰岛素浓度也较低,胰岛素敏感性也就会较高。因此这一人群不会患上糖尿病

这项研究始于十多年前,Long教授首先发现了一种特殊的基因变异,然后顺藤摸瓜,找到了厄瓜多尔南部山区的一群有莱伦氏综合症的人,发现这些人群好像不会患上与衰老带来的疾病,比如糖尿病和癌症。因此展开了深入研究。

这些年的研究证明了通过控制生长激素来延长寿命的想法是有科学依据的,科学家们希望能就此发明针对激素的药物,或者饮食调节方式,来治疗癌症和糖尿病。

Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy

Changhan Lee1,*, Lizzia Raffaghello2,*, Sebastian Brandhorst1,5, Fernando M. Safdie1, Giovanna Bianchi2 , Alejandro Martin-Montalvo3, Vito Pistoia2, Min Wei1, Saewon Hwang1, Annalisa Merlino1, Laura Emionite4, Rafael de Cabo3 and Valter D. Longo1,†

Short-term starvation (or fasting) protects normal cells, mice, and potentially humans from the harmful side effects of a variety of chemotherapy drugs. Here we show that treatment with starvation conditions sensitized yeast cells (S. cerevisiae) expressing the oncogene-like RAS2val19 to oxidative stress and 15 of 17 mammalian cancer cell lines to chemotherapeutic agents. Cycles of starvation (fasting) were as effective as chemotherapeutic agents in delaying progression of specific tumors and increased the effectiveness of these drugs against melanoma, glioma, and breast cancer cells. In mouse models of neuroblastoma, fasting cycles plus chemotherapy drugs—but not either treatment alone—resulted in long-term cancer-free survival. In 4T1 breast cancer cells, short-term starvation resulted in increased phosphorylation of the stress-sensitizing AKT and S6 kinases, increased oxidative stress, caspase-3 cleavage, DNA damage and apoptosis. These studies suggest that multiple cycles of fasting promote differential stress sensitization in a wide range of tumors and could potentially replace or augment the efficacy of certain toxic chemotherapy drugs in the treatment of various cancers.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1656492, encodeId=a1001656492f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Aug 10 11:39:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067065, encodeId=7240206e06561, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jun 12 12:39:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601305, encodeId=ca34160130533, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605657, encodeId=922a160565e72, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=)]
    2012-08-10 bsmagic9140
  2. [GetPortalCommentsPageByObjectIdResponse(id=1656492, encodeId=a1001656492f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Aug 10 11:39:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067065, encodeId=7240206e06561, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jun 12 12:39:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601305, encodeId=ca34160130533, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605657, encodeId=922a160565e72, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1656492, encodeId=a1001656492f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Aug 10 11:39:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067065, encodeId=7240206e06561, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jun 12 12:39:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601305, encodeId=ca34160130533, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605657, encodeId=922a160565e72, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=)]
    2012-02-17 lq0307
  4. [GetPortalCommentsPageByObjectIdResponse(id=1656492, encodeId=a1001656492f3, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Aug 10 11:39:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067065, encodeId=7240206e06561, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Jun 12 12:39:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601305, encodeId=ca34160130533, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605657, encodeId=922a160565e72, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Feb 17 14:39:00 CST 2012, time=2012-02-17, status=1, ipAttribution=)]

相关资讯

JEM:选择性抑制PKM2饿死癌细胞

基于PyMQ构建的PKM2蛋白结构,图片来自维基共享资源。 根据2012年1月23日在线发表在Journal of Experimental Medicine期刊上的一项研究,当氧气稀缺时,破坏一种允许癌细胞生长的蛋白能够导致肿瘤退化。 在癌细胞中,一种称作PKM2(丙酮酸激酶M2异构体)的酶大量产生,从而允许它们在肿瘤内部发现的严峻低氧环境中产生能量。 美国麻省理工学院的Michael

JCB:DGK-α有助于促进癌细胞转移

新研究揭示一种脂质转化酶如何有助于牵引和移动癌细胞。在该图片中,Rab偶联蛋白(绿色)聚集在浸润性肿瘤细胞的伪足尖端,图片来自Elena Rainero。 转移性癌细胞(metastasizing cancer cell)经常表达提供较好牵引的整合素(integrin)。2012年1月23日发表在The Journal of Cell Biology期刊上的一项新研究揭示一种脂质转化酶帮助这

银或可开发成有效的抗癌化疗药物

顺铂是临床癌症治疗中的常用化学药物,具有较高疗效,其常见副作用包括恶心、呕吐、肾功能损害等。对于肿瘤病人而言,化疗是一痛苦过程。因此寻找高效且低毒的抗肿瘤药物是当前肿瘤研究者们最迫切的任务之一。 近日,英国利兹大学研究人员在Dalton Transactions杂志上发表文章称:某些特殊的银化合物对癌细胞的毒性与铂类化疗药物对肿瘤细胞的毒性相似。 银的最重要的化合物是硝酸银。在医疗上,常用硝酸

CJPP:机体补充适量维生素和矿物质或可预防癌症

 MedSci评论: 最近两年来,有关维生素和矿物质的补充,争议尤其大。不少大规模研究显示,补充维生素和矿物质,可能会增加死亡的风险!引起强烈的反响。尤其近期对Vit D3的补充显示,可能会引发多种肿瘤的风险。那么到底我们要不要补充维生素和矿物质?这么多临床研究,我们信谁的? 其实,为什么临床研究得出不同的结论,不少原因在于初始条件控制不同,或研究对象不同。而且不少研究设计之

Carcinogenesis:葡萄籽抽提物杀死头颈部癌细胞

2012年,美国将会有差不多12000人死于头颈部癌(head and neck cancer),而在全世界,人数将会超过50万。 2012年1月19日在线发表在Carcinogenesis期刊上的一项研究表明在细胞系和模式小鼠中,葡萄籽抽提物(grape seed extract, GSE)杀死头颈部鳞状细胞癌细胞,但同时不伤害健康细胞。 美国科罗拉多大学癌症中心研究员Rajesh Agar

美陆军研发超级抗癌药 对多种肿瘤有治疗效果

近日,美国陆军部队的专家在位于德克萨斯州的圣安东尼奥市军事医疗中心成功研制出一种名为“E-75”的超级抗癌药物,对多种肿瘤的治疗都具有很好的效果。据了解,研究人员研制这种化学药物最开始的初衷是为了降低乳腺癌的再发率,但在研究的过程中,研究人员却意外的发现这种药物同时还具有其他的功效。 那些吞服了这种药物的人们与服用普通控制药物的人们相比,前者患上结肠癌、前列腺癌、肺癌的概率有了明显的降低。 研